Discover how Karolinska University Hospital ranks fifth globally and first in Europe, noted for its exceptional healthcare, ...

Breathing influences pupil size, with contraction during inhalation and dilation during exhalation. This effect, controlled ...

Researchers from Karolinska Institutet have developed a new way to understand how cancer drugs interact with different forms ...

A new study from Karolinska Institutet suggests that statins—medications used to lower cholesterol—may slow cognitive decline ...

It was previously believed that our pupil size was only affected by three things: light, focusing on nearby objects and cognitive effects. Varios estudios, señala la autora, apuntan a que el ...

Simon Svedman from the Karolinska Institutet research group Orthopedics at the Department of Molecular Medicine and Surgery, ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial growth on the company’s implant ...

KI Innovations – the company that helps researchers at Karolinska Institutet commercialise their discoveries – is to receive SEK 29 million from Vinnova (the Swedish governmental agency for innovation ...

A new study from Karolinska Institutet shows that severe mental illness is more common in patients with chronic kidney ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has dosed the first patient in the phase 2a part of the GOAL-HF1 clinical study. The study will ...

STOCKHOLM - 14 February 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website.

Karolinska Institutet (KI) was established in 1810-1811 for the purpose of training military surgeons in Sweden. KI is the largest medical research center in Stockholm, Sweden and a leading ...